Sarcopenia and preserved bone mineral density in paediatric survivors of high-risk neuroblastoma with growth failure.

Bone mineral density and adiposity are not severely impacted in HR-NBL survivors with growth failure, but significant sarcopenia persists years after treatment. Future studies are needed to determine if sarcopenia improves with muscle-specific interventions in this population of cancer survivors.